Abstract
Nothing is more fundamental in evidence-based clinical decision-making than understanding the diurnal glucose patterns that characterize dysglycemia. And, nothing is more fundamental to obtaining diurnal glucose patterns than continuous glucose monitoring (CGM). The significance of CGM cannot be overstated, whether the treatment decisions are for V˙. Glucose control is unequivocally of significance, and although the evidence remains equivocal as to the precise mechanisms glucose control provides prevent or slow the progression of complications, there is no doubt that its importance remains paramount. The argument can be summed up by Ceriello’s observation after examining diurnal glucose patterns of individuals with normal glucose tolerance: “If the human body spends so much energy to maintain the blood glucose level within such a narrow range, it is because otherwise it would be deleterious” (Ceriello and Ihnat. Diabetic Med 27(8):862–867, 2010). It has been established that individuals with normal glucose metabolism have the lower risk of glucose-related macrovascular, microvascular, as well as maternal and fetal complications when compared to individuals with any degree of dysglycemia.
Includes excerpts from Trainer Manual for Teaching and Interpretation of the Ambulatory Glucose Profile (AGP) Using the FreeStyle® Libre Pro Flash Glucose Monitoring System (with permission). Mazze R and Cranston I, AGP Clinical Academy publication 2017, Portsmouth UK
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Herranz L, Pallardo L-V, et al. Maternal third trimester hyperglycaemic excursions predict large-for-gestational-age infants in type 1 diabetic pregnancy. Diabetes Res Clin Pract. 2007;75(1):42–6.
Mazze R, Strock E, Borgman S, Wesley D, Stout P, Racchini J. Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): is CGM ready for real time? Diabetes Technol Ther. 2009;11(1):11.
Hoss U, Budiman E, Liu H, Christiansen H. Continuous glucose monitoring in the subcutaneous tissue over a 14-day sensor wear period. Diabetes Sci Technol. 2013;7(5):1210–9.
Xing D, Kollman C, Beck R, et al. Optimal sampling intervals to assess long-term glycaemic control using continuous glucose monitoring. Diab Tech Ther. 2011;13:351.
Mazze R, Strock E, Wesley D, Borgman S, Morgan B, Bergenstal R, Cuddihy R. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile (AGP) analysis. Diabetes Technol Ther. 2008;10(3):149.
Ceriello A, Ihnat MA. ‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting. Diabetic Med. 2010;27(8):862–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mazze, R.S. (2019). Continuous Glucose Monitoring in Clinical Practice: Ambulatory Glucose Profile and the Application of Advanced Glucose Sensing Technologies to Clinical Decision-Making. In: Rodriguez-Saldana, J. (eds) The Diabetes Textbook. Springer, Cham. https://doi.org/10.1007/978-3-030-11815-0_28
Download citation
DOI: https://doi.org/10.1007/978-3-030-11815-0_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11814-3
Online ISBN: 978-3-030-11815-0
eBook Packages: MedicineMedicine (R0)